Qsemble Capital Management’s Boston Scientific BSX Stock Holding History

Qsemble Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.2M	Buy	225,867 +97,901	+77%	+$7.83M	1.08%	2
2025 Q4	$12.2M	Buy	127,966 +50,313	+65%	+$4.93M	1.01%	6
2025 Q3	$7.58M	Buy	77,653 +57,242	+280%	+$5.93M	0.74%	35
2025 Q2	$2.19M	Sell	20,411 -7,152	-26%	-$724K	0.21%	150
2025 Q1	$2.78M	Buy	+27,563	New	+$2.78M	0.3%	124
2024 Q3	–	Sell	-34,926	Closed	-$2.69M	–	394
2024 Q2	$2.69M	Buy	+34,926	New	+$2.56M	0.51%	56
2023 Q3	–	Sell	-30,600	Closed	-$1.66M	–	328
2023 Q2	$1.66M	Buy	+30,600	New	+$1.6M	1.17%	11

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Qsemble Capital Management's BSX Position: Q1 2026 in Review

Qsemble Capital Management increased its Boston Scientific (BSX) stake by 77% in Q1 2026, buying an estimated $7.83M and bringing the position to 225,867 shares worth $14.2M. The position accounts for 1.08% of the portfolio, ranked #2.

Qsemble Capital Management first reported a position in BSX in Q2 2023 and has held it in 7 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Qsemble Capital Management held 225,867 shares of Boston Scientific worth $14.2M as of Q1 2026.
Qsemble Capital Management bought 97,901 Boston Scientific shares in Q1 2026, an estimated $7.83M.
Boston Scientific made up 1.08% of Qsemble Capital Management's portfolio in Q1 2026, its #2 holding.
Qsemble Capital Management first reported a position in Boston Scientific in Q2 2023 and has held it in 7 quarters since.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Qsemble Capital Management's 13F filing for Q1 2026, filed 7 May 2026.